Sarcoma Pharmacotherapy
Sarcoma Pharmacotherapy is a subfield of solid tumor pharmacotherapy that focuses on the rational selection, dosing, and clinical use of systemic and targeted drug therapies for the treatment of sarcomas, malignant tumors of mesenchymal origin.
2.3K
Publications
132.9K
Citations
11.1K
Authors
2.3K
Institutions
Publications per year
2017–2026
571
2.3K
Ian Judson, Jaap Verweij, Hans Gelderblom et al. · The Lancet Oncology · 2014 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +13
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
Giovanni Stallone, Antonio Schena, Barbara Infante et al. · New England Journal of Medicine · 2005 · 984 citations · Full text
Medicine, Immunology, Nephrology +12
1–5 of 2.3K
11.1K
57
h-index
38
h-index
37
h-index
37
h-index
34
h-index
1–5 of 11.1K
2.3K

Institut Gustave Roussy
Villejuif, France
61 h-index
379 publications
42.2K citations
Memorial Sloan Kettering Cancer Center
New York, United States
60 h-index
723 publications
79.8K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
59 h-index
498 publications
52.6K citations
Centre Léon Bérard
Lyon, France
58 h-index
297 publications
28.6K citations
Dana-Farber Cancer Institute
Boston, United States
50 h-index
333 publications
41.5K citations
National Cancer Institute
Bethesda, United States
46 h-index
289 publications
20.8K citations
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
46 h-index
434 publications
23.9K citations
Institut Bergonié
Bordeaux, France
42 h-index
218 publications
16.8K citations
1–8 of 2.3K
262 publications · 28.6K citations
91
h-index
149 publications · 11K citations
65
h-index
Repository · 268 publications · 11.4K citations
55
h-index
70 publications · 4.8K citations
42
h-index
64 publications · 5.3K citations
38
h-index
1–5